Oncology
Consultant – Medical Oncology14 years
Fortis Hospitals
Kolkata
Dr. Debapriya Mondal is a Consultant Medical Oncologist associated with Fortis Hospital, Anandapur, Kolkata. He is also listed with Apollo Multispeciality Hospitals, Kolkata. His practice focuses on the assessment and systemic treatment of cancer, including the use of chemotherapy, targeted therapies, immunotherapy and other medical oncology treatments.
Dr. Mondal holds an MBBS, MD in Radiation Oncology and DrNB in Medical Oncology. His postgraduate medical oncology training includes Tata Medical Center, and he has obtained additional specialist credentials through the Royal College of Physicians in the United Kingdom and the European Society for Medical Oncology.
His clinical interests include the management of solid tumours, particularly lung cancer and other thoracic malignancies. His documented expertise also encompasses breast cancer, gastrointestinal cancers and treatment planning using systemic anticancer medicines. Treatment decisions depend on cancer type, disease stage, molecular characteristics and the patient's overall health.
Dr. Debapriya Mondal has experience with chemotherapy protocols, targeted anticancer drugs, immunotherapy and biological cancer treatments. These approaches may be used independently or combined with surgery and radiotherapy as part of multidisciplinary cancer care. Patients undergo clinical evaluation and appropriate investigations before a treatment plan is recommended.
His academic achievements include recognition through the European Society for Medical Oncology Travel Award, the International Association for the Study of Lung Cancer Education Award and the Torrent Young Scholar Award. He has also participated in medical oncology research and academic activities related to cancer treatment.
Patients seeking a Medical Oncologist in Kolkata for lung cancer, breast cancer, gastrointestinal malignancies or systemic cancer treatment can consult Dr. Debapriya Mondal through his listed hospital affiliations. Appointment availability and specific treatment services should be confirmed with the relevant hospital.
Medical oncology consultation involves assessing patients with a confirmed or suspected cancer diagnosis and determining whether systemic anticancer treatment is appropriate. The oncologist reviews pathology reports, imaging results, medical history and relevant investigations. Treatment decisions are based on cancer type, disease stage and the patient's clinical condition.
Chemotherapy uses medicines that destroy cancer cells or interfere with their growth. It may be administered intravenously or orally, depending on the cancer and treatment regimen. The oncologist selects appropriate medications, monitors treatment response and manages possible side effects through regular clinical assessment.
Targeted cancer therapy uses medicines designed to act on particular molecules or pathways involved in cancer growth. Certain treatments require molecular or biomarker testing before use. Their suitability depends on the type of cancer, relevant tumour characteristics, prior treatment and the patient's overall health.
Immunotherapy is a form of cancer treatment that helps the immune system recognise or respond to cancer. Specific immunotherapy medicines may be suitable for selected malignancies based on clinical and biomarker findings. Patients require monitoring for treatment-related adverse effects, including immune-mediated complications.
Lung cancer treatment depends on the type of cancer, stage, molecular characteristics and general health of the patient. Medical oncology options may include chemotherapy, targeted medicines and immunotherapy. These treatments can be combined with surgery or radiotherapy when clinically appropriate and are often planned through a multidisciplinary team.
Systemic treatment for breast cancer may include chemotherapy, hormone-based medicines, targeted therapies or immunotherapy. The selected approach depends on tumour characteristics, receptor status, disease stage and previous treatments. Medical oncologists coordinate treatment with breast surgeons, radiation oncologists and other specialists as required.
Gastrointestinal cancers affect organs involved in digestion, including the stomach, intestines and related structures. Systemic treatment may involve chemotherapy, targeted medicines or immunotherapy depending on the diagnosis and tumour biology. Treatment planning considers staging investigations, patient health and multidisciplinary recommendations.
Solid tumours are cancers that develop in organs or tissues rather than primarily in blood-forming cells. Medical oncology management involves reviewing the diagnosis, determining disease extent and considering systemic anticancer treatments. The treatment strategy varies considerably across different tumour types and stages.
Biological therapies use medicines that interact with biological processes involved in cancer growth or immune responses. Some treatments target specific tumour proteins or signalling pathways. Selection depends on the cancer diagnosis, available biomarker information and evidence supporting the treatment for the individual patient.
Hormonal therapy is used in selected hormone-sensitive cancers, particularly certain breast and prostate cancers. These medicines work by reducing hormone production or blocking hormone-related signals that support cancer growth. Treatment depends on tumour characteristics, clinical guidelines and individual patient factors.
Complex chemotherapy planning involves selecting and coordinating anticancer medicines according to the cancer diagnosis, treatment goals and patient-related factors. The process may include laboratory assessments, evaluation of organ function and planning for supportive medications. Patients are monitored throughout treatment to identify toxicity or other complications.
Monitoring cancer treatment involves evaluating whether therapy is controlling disease and whether the patient is tolerating treatment. Assessments may include imaging, blood tests, physical examination and symptom review. Results help the oncologist determine whether treatment should continue, be adjusted or be changed.
Cancer and its treatments may cause symptoms such as pain, nausea, fatigue, appetite changes and weakness. Supportive management aims to reduce discomfort, identify complications and help patients maintain daily functioning. Care may involve medication adjustments, nutritional support and referral to palliative care or other specialists.
Multidisciplinary cancer care involves coordination between medical oncologists, surgeons, radiation oncologists, radiologists, pathologists and other healthcare professionals. Treatment planning considers the patient's diagnosis, disease stage and individual needs. This approach helps integrate different therapies into an appropriate overall cancer management strategy.
MBBS, MD (Radiation Oncology), DrNB (Medical Oncology), Specialty Certificate in Medical Oncology (MRCP UK Specialty Certificate Examination), European Certification in Medical Oncology
Medical Oncology Consultation, Solid Tumour Management, Lung Cancer Treatment, Breast Cancer Systemic Treatment, Gastrointestinal Cancer Treatment, Chemotherapy, Targeted Cancer Therapy, Immunotherapy, Biological Cancer Therapy, Hormonal Cancer Therapy, Complex Chemotherapy Planning, Systemic Cancer Treatment Assessment, Cancer Treatment Response Monitoring, Cancer-Related Symptom Management, Multidisciplinary Cancer Care Planning.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Debapriya Mondal
Dr. Debapriya Mondal specialises in Medical Oncology, focusing on systemic cancer treatments, including chemotherapy, targeted therapy and immunotherapy.
He holds MBBS, MD and DrNB qualifications in Medical Oncology, along with additional medical oncology certifications from UK and European professional institutions.
Fortis Healthcare lists 14 years of experience. Apollo Hospitals reports 10+ years, while another professional profile reports 14+ years.
Yes. Lung cancer and other thoracic malignancies are specifically mentioned among his areas of clinical expertise.
Yes. His professional profiles identify systemic chemotherapy, immunotherapy, targeted medicines and biological therapies among his clinical treatment areas.
Contact us for personalized help or to schedule an appointment.